Skip to main content
. Author manuscript; available in PMC: 2023 Jan 13.
Published in final edited form as: Biomark Neuropsychiatry. 2020 May 12;3:100014. doi: 10.1016/j.bionps.2020.100014

Table 1.

Demographics & clinical scales by group.

HC BDNP BDP SAD SZ Statistic p

N 415 66 171 201 225
Mean age 34.74 40.39 37.20 40.32 40.03 F(4,1073) = 11.89*** <.001
Age SD 12.50 12.16 11.72 10.98 11.66
Sex (% F) 57 71 54 55 38 x2(4) = 31.89*** <.001
N from each site x2(16) = 99.27*** <.001
Boston 90 8 25 19 36
Chicago 51 0 49 45 51
Dallas 81 25 40 36 46
Georgia 86 0 16 36 44
Hartford 107 33 41 65 48
Number of trials in each waveform average by group
Mean 114 114 113 113 113 F(4,1073) = .36 .84
SD 8.15 8.19 8.66 8.16 9.19
Global Assessment of Function (GAF) F(4,942) = 456.38*** <.001
F(3,606) = 10.84*** <.001
N 337 60 161 184 205 HC > BDNP***, BDP*** > SAD*, SZ***
M 83.42 57.88 56.73 53.26 50.51
SD 6.61 11.40 13.47 11.15 11.54
Birchwood Social Functioning Scale (SFS) F(4,985) = 158.54 <.001
F(3,605) = 17.82*** <.001
N 381 61 159 187 202 HC > BDNP***, BDP*** > SAD***, SZ*
M 154.15 130.15 131.11 116.78 117.33
SD 17.34 20.41 23.65 22.93 21.32
Positive and Negative Syndrome Scale (PANSS) Positive F(3,592) = 22.62*** <.001
N N/A 63 157 178 198 SZ, SAD > BDP***,
M N/A 12.76 13.82 17.85 17.71 BDNP***
SD N/A 3.64 5.86 6.92 6.29
PANSS Negative F(3,591) = 9.22*** <.001
N N/A 63 157 178 197 SZ > BDP***, BDNP*, SAD > BDP**
M N/A 14.57 13.85 16.32 17.39
SD N/A 5.86 6.44 7.16 6.71
PANSS General F(3,592) = 1.28 .28
N N/A 63 157 178 198
M N/A 31.67 31.06 33.16 32.24
SD N/A 8.83 10.59 9.87 10.00
PANSS Total F(3,591) = 8.18*** <.001
N N/A 63 157 178 197 SZ, SAD > BDP***, BDNP*
M N/A 59.00 58.72 67.33 67.42
SD N/A 15.84 21.12 21.39 20.15
Montgomery-Åsberg Depression Rating Scale (MADRS) F(3,600) = 8.90*** <.001
N N/A 63 159 183 199 SZ < SAD***, BDP***, BDNP**
M N/A 14.79 14.56 14.01 9.75
SD N/A 9.33 11.82 10.70 8.94
Young Mania Rating Scale (YMRS) F(3,599) = 1.64 .18
N N/A 63 159 181 200
M N/A 9.41 8.98 10.83 9.93
SD N/A 7.10 8.82 7.95 7.28

Note: HC, Healthy Subjects; SZ, Probands with schizophrenia; SAD, Probands with schizoaffective disorder; BDP, Probands with bipolar disorder I with a history of psychotic symptoms; BDNP, Probands with bipolar disorder I without a history of psychosis symptoms.

For scales with two sets of ANOVA statistics, the first was done including HC, and the second included only probands.

*

p < .05

**

p < .01

***

p < .001.

Group comparisons performed with Tukey tests.